Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Reviva Pharmaceuticals Holdings Inc | RVPH | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
2.96 | 2.91 | 3.0515 | 2.94 |
Noticias Recientes
Fecha | Hora | Fuente | Noticia |
---|---|---|---|
16/2/2024 | 15:32 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
13/2/2024 | 23:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
13/2/2024 | 16:00 | EDGAR2 | Form 424B4 - Prospectus [Rule 424(b)(4)] |
02/2/2024 | 15:38 | EDGAR2 | Form S-3 - Registration statement under Securities Act of.. |
17/11/2023 | 15:05 | EDGAR2 | Form 8-K - Current report |
17/11/2023 | 15:03 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
14/11/2023 | 15:12 | EDGAR2 | Form 8-K - Current report |
30/10/2023 | 07:20 | EDGAR2 | Form 8-K - Current report |
04/10/2023 | 16:03 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
04/10/2023 | 16:02 | EDGAR2 | Form 8-K - Current report |
17/8/2023 | 05:30 | EDGAR2 | Form 8-K - Current report |
14/8/2023 | 15:16 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
14/8/2023 | 15:15 | EDGAR2 | Form 8-K - Current report |
24/7/2023 | 15:16 | EDGAR2 | Form 8-K - Current report |